other material
confidence high
sentiment neutral
materiality 0.50
Cellectar reports share count update after warrant exercises; 30.45M common shares outstanding as of Jan 31, 2024
Cellectar Biosciences, Inc.
- Common shares outstanding: 30,452,042 as of January 31, 2024, up from prior count due to Tranche A and other warrant exercises since November 2023.
- Preferred stock outstanding: 319.76 Series E-2, 918.00 Series E-3, and 111 Series D preferred shares.
- Warrant exercises increased share count, diluting existing common stockholders.
- No business updates or financial results provided; filing solely updates capital structure.